News
Announcement on behalf of major subsidiary,TOP Biological Technology Company Limited to Merge into TOP PHARM.MEDICALWARE COMPAN
2024.11.15
...
More
TSH Board of Directors Approved the Consolidated Financial Statements For the Nine Months Ended September 30,2024
2024.11.8
...
More
To announce the expected date of the board of directors meeting to approve the consolidated financial statements for the third
2024.10.30
...
More
Announcement on behalf of major subsidiary,CHUANG YI BIOTECH CO., LTD.,regarding acquisition of right-of-use asset from a relat
2024.10.1
...
More
Announced that the cumulative disposition of securities has reached the announcement standard.
2024.9.24
...
More
TSH Biopharm was invited to attend the online institutional investor conference hosted by Reliance Securities
2024.9.13
...
More